Cochrane Abstracts
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alemtuzumab for Patients With Chronic Lymphocytic Leukaemia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434436/1/Alemtuzumab_for_patients_with_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review. Accessed 03 June 2023.
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/1/Alemtuzumab_for_patients_with_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review. Accessed June 3, 2023.
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/1/Alemtuzumab_for_patients_with_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review
Alemtuzumab for Patients With Chronic Lymphocytic Leukaemia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 June 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/1/Alemtuzumab_for_patients_with_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
ID - 434436
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/1/Alemtuzumab_for_patients_with_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
